Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Cullinan Therapeutics Inc shares valued at $125,120 were sold by Michaelson Jennifer on Nov 05 ’24. At $15.64 per share, Michaelson Jennifer sold 8,000 shares. The insider’s holdings dropped to 107,942 shares worth approximately $1.36 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, Michaelson Jennifer sold 8,000 shares, netting a total of over 144,720 in proceeds. Following the sale of shares at $18.09 each, the insider now holds 115,942 shares.
Before that, JENNIFER MICHAELSON & MARC D M had added 16,000 shares to its account. In a trade valued at $298,880, the Officer bought Cullinan Therapeutics Inc shares for $18.68 each.
As published in their initiating research note from UBS on October 24, 2024, Cullinan Therapeutics Inc [CGEM] has been a Buy and the price target has been revised to $30. Analysts at Stifel started covering the stock with ‘”a Buy”‘ outlook in a report released in early May. As of April 15, 2024, William Blair has initiated its “an Outperform” rating for CGEM. Earlier on February 15, 2024, Wedbush initiated its rating. Their recommendation was “an Outperform” for CGEM stock.
Analyzing CGEM Stock Performance
During the last five days, there has been a drop of approximately -20.33%. Over the course of the year, Cullinan Therapeutics Inc shares have jumped approximately 23.45%. Shares of the company reached a 52-week high of $30.19 on 05/07/24 and a 52-week low of $10.00 on 01/11/24. A 50-day SMA is recorded $16.24, while a 200-day SMA reached $18.44. Nevertheless, trading volume fell to 0.85 million shares from 0.49 million shares the previous day.
Support And Resistance Levels for Cullinan Therapeutics Inc (CGEM)
According to the 24-hour chart, there is a support level at 12.22, which, if violated, would cause prices to drop to 11.85. In the upper region, resistance lies at 13.23. The next price resistance is at 13.88. RSI (Relative Strength Index) is 30.11 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -2.18, which suggests the price will decrease in the coming days. Percent R is at 98.40%, indicating bearish price movement. Stochastics %K at buying indicates that the stock is to be held.
